Berenberg Bank cuts Reckitt Benckiser Group (OTCMKTS:RBGLY) price target to 7,050 GBX

Reckitt Benckiser Group (OTCMKTS:RBGLY – Get Rating) had its price target reduced by analysts at Berenberg Bank from 8,200 GBX ($99.08) to 7,050 GBX ($85.19) in a research report released Friday to clients and investors, reports The Fly .

Several other stock analysts have also recently released reports on the company. Sanford C. Bernstein upgraded the Reckitt Benckiser Group from an “underperforming” rating to a “market performing” rating in a Thursday, July 28, report. Barclays cut its price target on Reckitt Benckiser Group from 8,900 GBX ($107.54) to 8,200 GBX ($99.08) in a report on Thursday. Finally, UBS Group raised its price target on Reckitt Benckiser Group from 8,400 GBX ($101.50) to 8,700 GBX ($105.12) in a Thursday, July 28 report. Two research analysts rated the stock with a sell rating, two assigned a hold rating and one issued a buy rating for the company’s stock. Based on MarketBeat data, Reckitt Benckiser Group currently has a consensus rating of “Hold” and a consensus target price of $7,612.50.

Reckitt Benckiser Group shares fall 2.7%

RBGLY stock fell $0.36 on Friday, hitting $12.88. 1,243,282 shares of the company were traded, against an average volume of 1,223,522. Reckitt Benckiser Group has a 12-month low of $12.71 and a 12-month high of $17.90. The company has a 50-day moving average price of $14.19 and a two-hundred-day moving average price of $15.17. The company has a quick ratio of 0.47, a current ratio of 0.70 and a debt ratio of 0.84.

Reckitt Benckiser Group Company Profile

(Get an evaluation)

Reckitt Benckiser Group plc manufactures and sells health, hygiene and nutrition products in the UK, USA, China, India and internationally. The company offers acne treatment creams, facial cleansers and cleansing pads; disinfection, hygiene and first aid products; condoms, sex toys and lubricants; solutions for heartburn and indigestion; and cough and chest congestion, multiple symptom and sinus remedies for adults and children under the brand names Clearasil, Dettol, Durex, Gaviscon and Mucinex.

Featured articles

The Fly logo

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Reckitt Benckiser Group, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market ripples…and Reckitt Benckiser Group didn’t make the list.

Although Reckitt Benckiser Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

About Sally Dominguez

Check Also

Perfect Corp extends AI/VR beyond skincare

In 2022, it’s hard to imagine a beauty market without AI/VR. These high-tech tools help …